159 related articles for article (PubMed ID: 11675048)
1. FR226807: a potent and selective phosphodiesterase type 5 inhibitor.
Hosogai N; Hamada K; Tomita M; Nagashima A; Takahashi T; Sekizawa T; Mizutani T; Urano Y; Kuroda A; Sawada K; Ozaki T; Seki J; Goto T
Eur J Pharmacol; 2001 Oct; 428(2):295-302. PubMed ID: 11675048
[TBL] [Abstract][Full Text] [Related]
2. Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor.
Mochida H; Takagi M; Inoue H; Noto T; Yano K; Fujishige K; Sasaki T; Yuasa K; Kotera J; Omori K; Kikkawa K
Eur J Pharmacol; 2002 Dec; 456(1-3):91-8. PubMed ID: 12450574
[TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859.
Qiu Y; Bhattacharjee S; Kraft P; John TM; Craig E; Haynes-Johnson D; Guan J; Jiang W; Macielag M; Sui Z; Clancy J; Lundeen S
Eur J Pharmacol; 2003 Jul; 472(1-2):73-80. PubMed ID: 12860475
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.
Takagi M; Mochida H; Noto T; Yano K; Inoue H; Ikeo T; Kikkawa K
Eur J Pharmacol; 2001 Jan; 411(1-2):161-168. PubMed ID: 11137871
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.
Wallis RM; Corbin JD; Francis SH; Ellis P
Am J Cardiol; 1999 Mar; 83(5A):3C-12C. PubMed ID: 10078537
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors.
Wang Y; Chackalamannil S; Hu Z; Boyle CD; Lankin CM; Xia Y; Xu R; Asberom T; Pissarnitski D; Stamford AW; Greenlee WJ; Skell J; Kurowski S; Vemulapalli S; Palamanda J; Chintala M; Wu P; Myers J; Wang P
Bioorg Med Chem Lett; 2002 Nov; 12(21):3149-52. PubMed ID: 12372521
[TBL] [Abstract][Full Text] [Related]
9. 1,7- and 2,7-naphthyridine derivatives as potent and highly specific PDE5 inhibitors.
Ukita T; Nakamura Y; Kubo A; Yamamoto Y; Moritani Y; Saruta K; Higashijima T; Kotera J; Fujishige K; Takagi M; Kikkawa K; Omori K
Bioorg Med Chem Lett; 2003 Jul; 13(14):2341-5. PubMed ID: 12824030
[TBL] [Abstract][Full Text] [Related]
10. The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit.
Thompson CS; Mumtaz FH; Khan MA; Wallis RM; Mikhailidis DP; Morgan RJ; Angelini GD; Jeremy JY
Eur J Pharmacol; 2001 Aug; 425(1):57-64. PubMed ID: 11672575
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159.
Doh H; Shin CY; Son M; Ko JI; Yoo M; Kim SH; Kim WB
Arch Pharm Res; 2002 Dec; 25(6):873-8. PubMed ID: 12510841
[TBL] [Abstract][Full Text] [Related]
12. The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5.
Wallis RM
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():22P-26P. PubMed ID: 10629850
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase type 5 inhibition ameliorates nephrotoxicity induced by cyclosporin A in spontaneous hypertensive rats.
Hosogai N; Tomita M; Hamada K; Ogawa T; Hirosumi J; Manda T; Mutoh S
Eur J Pharmacol; 2003 Sep; 477(2):171-8. PubMed ID: 14519421
[TBL] [Abstract][Full Text] [Related]
14. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
Qiu Y; Kraft P; Lombardi E; Clancy J
J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
[TBL] [Abstract][Full Text] [Related]
15. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.
Filippi S; Crescioli C; Vannelli GB; Fazzini A; Natali A; Riffaud JP; Maggi M; Ledda F
Int J Androl; 2003 Apr; 26(2):101-8. PubMed ID: 12641828
[TBL] [Abstract][Full Text] [Related]
16. Novel, potent, and selective phosphodiesterase 5 inhibitors: synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivatives.
Ukita T; Nakamura Y; Kubo A; Yamamoto Y; Moritani Y; Saruta K; Higashijima T; Kotera J; Takagi M; Kikkawa K; Omori K
J Med Chem; 2001 Jun; 44(13):2204-18. PubMed ID: 11405657
[TBL] [Abstract][Full Text] [Related]
17. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.
Ballard SA; Gingell CJ; Tang K; Turner LA; Price ME; Naylor AM
J Urol; 1998 Jun; 159(6):2164-71. PubMed ID: 9598563
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacological profiles of sildenafil (VIAGRA) in the treatment of erectile dysfunction: efficacy and drug interaction with nitrate].
Omote M
Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):213-8. PubMed ID: 10584234
[TBL] [Abstract][Full Text] [Related]
19. A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa.
El-Thaher TS; Khatib S; Saleem M; Shnoudeh A; Badwan AA
Int J Impot Res; 2002 Dec; 14(6):453-61. PubMed ID: 12494277
[TBL] [Abstract][Full Text] [Related]
20. KF31327, a new potent and selective inhibitor of cyclic nucleotide phosphodiesterase 5.
Hirose R; Okumura H; Yoshimatsu A; Irie J; Onoda Y; Nomoto Y; Takai H; Ohno T; Ichimura M
Eur J Pharmacol; 2001 Nov; 431(1):17-24. PubMed ID: 11716838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]